CapitalBio Technology

CapitalBio Technology is a leading Chinese life sciences company specializing in the development and commercialization of biochip-based products and services. Founded as a spin-off from Tsinghua University, the company provides a comprehensive range of solutions including microarrays, molecular diagnostic kits, and laboratory automation instruments. Their portfolio addresses critical healthcare needs in areas such as infectious disease testing, genetic screening for hereditary hearing loss, and personalized medicine. CapitalBio also offers health management services and big data analytics to support precision healthcare. The company serves clinical, research, and industrial customers globally with a strong focus on innovation in microfluidics and lab-on-a-chip technologies.